A prospective, blinded, monadic comparative sensory study of three topical pain relief spray formulations.
Main Article Content
Abstract
Introduction: Oral drugs are commonly prescribed for the treatment of acute pain. Other than these agents, certain anticonvulsants and antidepressants are also prescribed for chronic pain. Although being effective in providing pain relief, oral administration frequently results in systemic adverse drug reactions (ADRs), which may prevent their ongoing use and result in their discontinuation. Topical analgesics are useful to provide symptomatic benefits seen with oral agents but devoid of the systemic ADRs. Essential oils extracted from plants, some of which are known analgesic compounds like methyl salicylate, eucalyptus oil, clove oil, menthol, turpentine oil which form contents of the newly launched Iodex rapid action spray along with excipients. The aim of this study was to evaluate the sensorial profiling of newly launched Iodex rapid action spray in meeting the consumer expectations as topical pain relief spray. The other objective was to validate consumer perception of the product’s sensorial claims and appeal.
Methods: This study was a prospective, blinded, monadic comparison, consumer sensory study conducted in 3 different cities in India. Participants were pre-recruited to try 3 different pain relief spray formulations, 30 min session per day. One product to be tested each day. The participants had to use the product and answer the questionnaire online. Only Sensorial aspects were checked.
Results: Comparing the market sample 1 (Iodex rapid action spray) vs other formulations, all 3 products got very high level of consumer agreement. For the monadic score, market sample 1 was equal to if not better to than the other two i.e., market sample 2 and market sample 3 in regard to the sensory and participant liking claims.
Conclusion: Market sample 1 (Iodex rapid action spray) got very high level of consumer agreement. Market sample 1 (Iodex rapid action spray) is equal to if not better to than the other two i.e., market sample 2 and market sample 3 regards to the sensory and liking claims.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Jorge LL, Feres CC, Teles VE. Topical preparations for pain relief: efficacy and patient adherence. J Pain Res. 2010 Dec 20;4:11-24.
II. Albert Dahan, Leon Aarts, Terry W. Smith; Incidence, Reversal, and Prevention of Opioid-induced Respiratory Depression. Anesthesiology 2010; 112:226–238
III. Oyler DR, Parli SE, Bernard AC, Chang PK, Procter LD, Harned ME. Nonopioid management of acute pain associated with trauma: Focus on pharmacologic options. J Trauma Acute Care Surg. 2015 Sep;79(3):475-83.
IV. Bindu S, Mazumder S, Bandyopadhyay U. Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective. Biochem Pharmacol. 2020;180:114147.
V. Leppert W. Pain management in patients with cancer: focus on opioid analgesics [published correction appears in Curr Pain Headache Rep. 2011 Dec;15(6):422. Dosage error in article text]. Curr Pain Headache Rep. 2011;15(4):271-279.
VI. Harirforoosh, S., Asghar, W., & Jamali, F. (2014). Adverse Effects of Nonsteroidal Antiinflammatory Drugs: An Update of Gastrointestinal, Cardiovascular and Renal Complications. J. Pharm. Pharm. Sci., 16(5), 821–847
VII. Gor AP, Saksena M. Adverse drug reactions of nonsteroidal anti-inflammatory drugs in orthopedic patients. J Pharmacol Pharmacother. 2011;2(1):26-29. doi:10.4103/0976-500X.77104
VIII. Glasgow JF. Reye's syndrome: the case for a causal link with aspirin. Drug Saf. 2006;29(12):1111-21.
IX. Zacher J, Altman R, Bellamy N, Brühlmann P, Da Silva J, Huskisson E, Taylor RS. Topical diclofenac and its role in pain and inflammation: an evidence-based review. Curr Med Res Opin. 2008 Apr;24(4):925-50
X. Heyneman CA, Lawless-Liday C, Wall GC. Oral versus topical NSAIDs in rheumatic diseases: a comparison. Drugs. 2000 Sep;60(3):555-74
XI. Haroutiunian S, Drennan DA, Lipman AG. Topical NSAID therapy for musculoskeletal pain. Pain Med. 2010 Apr;11(4):535-49.
XII. Sachs CJ. Oral analgesics for acute nonspecific pain. Am Fam Physician. 2005 Mar 1;71(5):913-8.
XIII. Mason L, Moore RA, Edwards JE, Derry S, McQuay HJ. Topical NSAIDs for chronic musculoskeletal pain: systematic review and meta-analysis. BMC Musculoskelet Disord. 2004 Aug 19;5:28.
XIV. Mason L, Moore RA, Edwards JE, Derry S, McQuay HJ. Topical NSAIDs for acute pain: a meta-analysis. BMC Fam Pract. 2004 May 17;5:10
XV. Hróbjartsson A, Gøtzsche PC. Placebo interventions for all clinical conditions. Cochrane Database Syst Rev. 2010;2010(1):CD003974. Published 2010 Jan 20.
XVI. Sarmento-Neto JF, do Nascimento LG, Felipe CF, de Sousa DP. Analgesic Potential of Essential Oils. Molecules. 2015;21(1):E20. Published 2015 Dec 23.
XVII. Barkin RL. The pharmacology of topical analgesics. Postgrad Med. 2013 Jul;125(4 Suppl 1):7-18.
XVIII. Silva J, Abebe W, Sousa SM, Duarte VG, Machado MI, Matos FJ. Analgesic and anti-inflammatory effects of essential oils of Eucalyptus. J Ethnopharmacol. 2003 Dec;89(2-3):277-83.
XIX. Jadhav BK, Khandelwal KR, Ketkar AR, Pisal SS. Formulation and evaluation of mucoadhesive tablets containing eugenol for the treatment of periodontal diseases. Drug Dev Ind Pharm. 2004 Feb;30(2):195-203.
XX. Galeotti N, Di Cesare Mannelli L, Mazzanti G, Bartolini A, Ghelardini C. Menthol: a natural analgesic compound. Neurosci Lett. 2002 Apr 12;322(3):145-8
XXI. de Cássia da Silveira E Sá R, Lima TC, da Nóbrega FR, de Brito AEM, de Sousa DP. Analgesic-Like Activity of Essential Oil Constituents: An Update. Int J Mol Sci. 2017;18(12):2392. Published 2017 Dec 9.
XXII. Musharraf MU, Ahmad Z, Yaqub Z. Comparison of topical capsaicin and topical turpentine Oil for treatment of painful diabetic neuropathy. J Ayub Med Coll Abbottabad. 2017 Jul-Sep;29(3):384-387.
XXIII. Mandal UK, Chtterjee B and Pauzi FHB. (2016). A Review on Transdermal Spray: Formulation Aspect. M J Phar. 2(1): 006.
XXIV. Ibrahim, Sarah A (2015). Spray-on transdermal drug delivery systems. Expert Opin. Drug Deliv., 12(2), 195–205.
XXV. Higashi Y, Kiuchi T, Furuta K. Efficacy and safety profile of a topical methyl salicylate and menthol patch in adult patients with mild to moderate muscle strain: a randomized, double-blind, parallel-group, placebo-controlled, multicenter study. Clin Ther. 2010 Jan;32(1):34-43
XXVI. Nawaz, Allah & Feroz, Majid & Alam, Kamran & Sheikh, Zeeshan Ahmed & Usmanghani, Khan. (2015). Clinical efficacy of polyherbal formulation Eezpain spray for muscular pain relief. Pak. J. Pharm. Sci. 27.
XXVII. Mohammadi Nejad S, Özgüneş H, Başaran N. Pharmacological and Toxicological Properties of Eugenol. Turk J Pharm Sci. 2017;14(2):201-206.